These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23449406)

  • 41. Hepatitis C virus: molecular biology and genetic variability.
    Bréchot C
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):6S-21S. PubMed ID: 9011478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
    Kurachi S; Koizumi N; Sakurai F; Kawabata K; Sakurai H; Nakagawa S; Hayakawa T; Mizuguchi H
    Gene Ther; 2007 Feb; 14(3):266-74. PubMed ID: 17006548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression of HCV genes using adenovirus vector with CAG promoter].
    Makimura M; Suzuki A; Matsuura Y; Miyamura T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):91-4. PubMed ID: 7563901
    [No Abstract]   [Full Text] [Related]  

  • 44. New therapeutic opportunities for hepatitis C based on small RNA.
    Pan QW; Henry SD; Scholte BJ; Tilanus HW; Janssen HL; van der Laan LJ
    World J Gastroenterol; 2007 Sep; 13(33):4431-6. PubMed ID: 17724797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of hepatitis C virus cDNA in human hepatoma cell line mediated by a hybrid baculovirus-HCV vector.
    Fipaldini C; Bellei B; La Monica N
    Virology; 1999 Mar; 255(2):302-11. PubMed ID: 10069956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular and molecular biology of HCV infection and hepatitis.
    Tang H; Grisé H
    Clin Sci (Lond); 2009 Jun; 117(2):49-65. PubMed ID: 19515018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
    Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA
    Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
    Kumar A; Das S; Mullick R; Lahiri P; Tatineni R; Goswami D; Bhat P; Torresi J; Gowans EJ; Karande AA; Das S
    Vaccine; 2016 Feb; 34(8):1115-25. PubMed ID: 26700891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NF-κB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector.
    Machitani M; Sakurai F; Wakabayashi K; Nakatani K; Shimizu K; Tachibana M; Mizuguchi H
    Sci Rep; 2016 Jan; 6():19922. PubMed ID: 26814140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation.
    Kato N
    Microb Comp Genomics; 2000; 5(3):129-51. PubMed ID: 11252351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.
    Hodges BL; Serra D; Hu H; Begy CA; Chamberlain JS; Amalfitano A
    J Gene Med; 2000; 2(4):250-9. PubMed ID: 10953916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
    Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
    J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic heterogeneity of the hepatitis C virus.
    Bukh J; Miller RH; Purcell RH
    Princess Takamatsu Symp; 1995; 25():75-91. PubMed ID: 8875612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens.
    Young KG; Haq K; MacLean S; Dudani R; Elahi SM; Gilbert R; Weeratna RD; Krishnan L
    J Viral Hepat; 2018 Jun; 25(6):649-660. PubMed ID: 29316037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of transgene expression mediated by several Fiber-modified adenovirus vectors in trophoblast cells.
    Koizumi N; Kondoh M; Mizuguchi H; Nakanishi T; Masuyama A; Ida F; Fujii M; Hayakawa T; Nakashima E; Tanaka K; Watanabe Y
    Placenta; 2005 Nov; 26(10):729-34. PubMed ID: 16226122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D.
    Ruzsics Z; Wagner M; Osterlehner A; Cook J; Koszinowski U; Burgert HG
    J Virol; 2006 Aug; 80(16):8100-13. PubMed ID: 16873266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term elimination of hepatitis C virus from human hepatocyte chimeric mice after interferon-γ gene transfer.
    Takahashi Y; Ando M; Nishikawa M; Hiraga N; Imamura M; Chayama K; Takakura Y
    Hum Gene Ther Clin Dev; 2014 Mar; 25(1):28-39. PubMed ID: 24279674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid construction of small interfering RNA-expressing adenoviral vectors on the basis of direct cloning of short hairpin RNA-coding DNAs.
    Mizuguchi H; Funakoshi N; Hosono T; Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T
    Hum Gene Ther; 2007 Jan; 18(1):74-80. PubMed ID: 17187476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo.
    Fiedler M; Rödicker F; Salucci V; Lu M; Aurisicchio L; Dahmen U; Jun L; Dirsch O; Pützer BM; Palombo F; Roggendorf M
    J Virol; 2004 Sep; 78(18):10111-21. PubMed ID: 15331744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.